Due to its differential expression in medulloblastomas, as well as the fact that it is normally only expressed in the epididymis, GPR64 represents a promising candidate for the development of imaging or radiotherapeutic agents that could be potentially efficacious not only in WNT subgroup medulloblastomas, but also Ewing’s sarcoma. Here, ADGRG2 is linked to Ewing sarcoma.